TSPO acts as an immune resistance gene involved in the T cell mediated immune control of glioblastoma

Glioblastoma (GB) IDH-wildtype is the most malignant primary brain tumor. It is particularly resistant to current immunotherapies. Translocator protein 18 kDa (TSPO) is upregulated in GB and correlates with malignancy and poor prognosis, but also with increased immune infiltration. Here, we studied...

Descripción completa

Detalles Bibliográficos
Autores principales: Menevse, Ayse N., Ammer, Laura-Marie, Vollmann-Zwerenz, Arabel, Kupczyk, Marcell, Lorenz, Julia, Weidner, Lorraine, Hussein, Abir, Sax, Julian, Mühlbauer, Jasmin, Heuschneider, Nicole, Rohrmus, Celine, Mai, Laura S., Jachnik, Birgit, Stamova, Slava, Volpin, Valentina, Durst, Franziska C., Sorrentino, Antonio, Xydia, Maria, Milenkovic, Vladimir M., Bader, Stefanie, Braun, Frank K., Wetzel, Christian, Albert, Nathalie L., Tonn, Joerg-Christian, Bartenstein, Peter, Proescholdt, Martin, Schmidt, Nils O., Linker, Ralf A., Riemenschneider, Markus J., Beckhove, Philipp, Hau, Peter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10165826/
https://www.ncbi.nlm.nih.gov/pubmed/37158962
http://dx.doi.org/10.1186/s40478-023-01550-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10165826/
https://www.ncbi.nlm.nih.gov/pubmed/37158962
http://dx.doi.org/10.1186/s40478-023-01550-9

Ejemplares similares